• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LOX-1 K167N多态性的功能分析与分子动力学模拟揭示受体活性改变。

Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.

作者信息

Biocca Silvia, Falconi Mattia, Filesi Ilaria, Baldini Francesco, Vecchione Lucia, Mango Ruggiero, Romeo Francesco, Federici Giorgio, Desideri Alessandro, Novelli Giuseppe

机构信息

Department of Neuroscience, University of Tor Vergata, Rome, Italy.

出版信息

PLoS One. 2009;4(2):e4648. doi: 10.1371/journal.pone.0004648. Epub 2009 Feb 27.

DOI:10.1371/journal.pone.0004648
PMID:19247493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2645694/
Abstract

The human lectin-like oxidized low density lipoprotein receptor 1 LOX-1, encoded by the ORL1 gene, is the major scavenger receptor for oxidized low density lipoprotein in endothelial cells. Here we report on the functional effects of a coding SNP, c.501G>C, which produces a single amino acid change (K>N at codon 167). Our study was aimed at elucidating whether the c.501G>C polymorphism changes the binding affinity of LOX-1 receptor altering its function. The presence of p.K167N mutation reduces ox-LDL binding and uptake. Ox-LDL activated extracellular signal-regulated kinases 1 and 2 (ERK 1/2) is inhibited. Furthermore, ox-LDL induced biosynthesis of LOX-1 receptors is dependent on the p.K167N variation. In human macrophages, derived from c.501G>C heterozygous individuals, the ox-LDL induced LOX-1 46 kDa band is markedly lower than in induced macrophages derived from c.501G>C controls. Investigation of p.K167N mutation through molecular dynamics simulation and electrostatic analysis suggests that the ox-LDL binding may be attributed to the coupling between the electrostatic potential distribution and the asymmetric flexibility of the basic spine residues. The N/N-LOX-1 mutant has either interrupted electrostatic potential and asymmetric fluctuations of the basic spine arginines.

摘要

由ORL1基因编码的人凝集素样氧化低密度脂蛋白受体1(LOX-1)是内皮细胞中氧化低密度脂蛋白的主要清道夫受体。在此,我们报告了一个编码单核苷酸多态性(SNP)c.501G>C的功能效应,该SNP导致单个氨基酸改变(密码子167处的K>N)。我们的研究旨在阐明c.501G>C多态性是否会改变LOX-1受体的结合亲和力,从而改变其功能。p.K167N突变的存在降低了氧化型低密度脂蛋白(ox-LDL)的结合和摄取。ox-LDL激活的细胞外信号调节激酶1和2(ERK 1/2)受到抑制。此外,ox-LDL诱导的LOX-1受体生物合成依赖于p.K167N变异。在源自c.501G>C杂合个体的人类巨噬细胞中,ox-LDL诱导的46 kDa LOX-1条带明显低于源自c.501G>C对照个体的诱导巨噬细胞。通过分子动力学模拟和静电分析对p.K167N突变的研究表明,ox-LDL的结合可能归因于静电势分布与碱性脊柱残基不对称柔韧性之间的耦合。N/N-LOX-1突变体的碱性脊柱精氨酸的静电势和不对称波动均被打断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/653a2295f7f4/pone.0004648.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/78a7aba74a0b/pone.0004648.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/07074134699d/pone.0004648.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/f99cc386ce51/pone.0004648.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/1282815da9a5/pone.0004648.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/43426da8bf1d/pone.0004648.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/ec6b3a649690/pone.0004648.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/653a2295f7f4/pone.0004648.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/78a7aba74a0b/pone.0004648.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/07074134699d/pone.0004648.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/f99cc386ce51/pone.0004648.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/1282815da9a5/pone.0004648.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/43426da8bf1d/pone.0004648.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/ec6b3a649690/pone.0004648.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867e/2645694/653a2295f7f4/pone.0004648.g007.jpg

相似文献

1
Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.LOX-1 K167N多态性的功能分析与分子动力学模拟揭示受体活性改变。
PLoS One. 2009;4(2):e4648. doi: 10.1371/journal.pone.0004648. Epub 2009 Feb 27.
2
Dominant-negative lox-1 blocks homodimerization of wild-type lox-1-induced cell proliferation through extracellular signal regulated kinase 1/2 activation.显性负性lox-1通过细胞外信号调节激酶1/2激活来阻断野生型lox-1诱导的细胞增殖的同二聚化。
Hypertension. 2006 Aug;48(2):294-300. doi: 10.1161/01.HYP.0000229825.98545.5e. Epub 2006 Jul 3.
3
Molecular mechanism of statin-mediated LOX-1 inhibition.他汀类药物介导的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抑制的分子机制。
Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.
4
LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus.妊娠糖尿病患者中LOX-1基因变异与母体血浆氧化型低密度脂蛋白及丙二醛水平
Arch Gynecol Obstet. 2016 Mar;293(3):517-27. doi: 10.1007/s00404-015-3851-6. Epub 2015 Aug 22.
5
Is LOX-1 K167N polymorphism protective for coronary artery disease?LOX-1 K167N 多态性对冠状动脉疾病有保护作用吗?
In Vivo. 2009 Nov-Dec;23(6):969-73.
6
Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.鱼精蛋白可能通过抑制氧化型低密度脂蛋白与凝集素样氧化型低密度脂蛋白受体1(LOX-1)的结合而具有抗动脉粥样硬化的潜力。
Biosci Biotechnol Biochem. 2019 Jun;83(6):1094-1101. doi: 10.1080/09168451.2019.1588096. Epub 2019 Mar 15.
7
The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3'UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population.土耳其人群中凝集素样氧化型低密度脂蛋白受体1(LOX-1)K167N和3'UTR188C>T多态性与孕妇血浆可溶性LOX-1水平及子痫前期风险的关联
Arch Gynecol Obstet. 2015 Mar;291(3):563-71. doi: 10.1007/s00404-014-3457-4. Epub 2014 Sep 9.
8
[Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages].[前蛋白转化酶枯草溶菌素9对凝集素样氧化型低密度脂蛋白受体-1介导的THP-1衍生巨噬细胞摄取氧化型低密度脂蛋白的影响及机制]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 May 24;47(5):367-373. doi: 10.3760/cma.j.issn.0253-3758.2019.05.007.
9
LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains.凝集素样氧化型低密度脂蛋白受体1在巨噬细胞响应氧化型低密度脂蛋白迁移中的作用及钙蛋白酶的参与
Biochem Biophys Res Commun. 2015 Nov 6;467(1):135-9. doi: 10.1016/j.bbrc.2015.09.100. Epub 2015 Sep 21.
10
Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids.成纤维细胞中黏附分子的表达:用LOX-1质粒转染后成纤维细胞生物学特性的改变。
Hypertension. 2005 Sep;46(3):622-7. doi: 10.1161/01.HYP.0000179045.95915.b0. Epub 2005 Aug 22.

引用本文的文献

1
LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.LOX-1 变体调节心血管疾病的严重程度:最新进展和未来方向。
Mol Cell Biochem. 2024 Sep;479(9):2245-2254. doi: 10.1007/s11010-023-04859-0. Epub 2023 Oct 3.
2
Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.洛辛可降低高脂饮食喂养小鼠肝脏的炎症反应和主动脉脂肪条纹形成。
Int J Mol Sci. 2022 Jun 30;23(13):7329. doi: 10.3390/ijms23137329.
3
E670G polymorphism increases risk of coronary artery disease in a Chinese Han population.

本文引用的文献

1
Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.未能复制氧化型低密度脂蛋白受体基因(OLR1)的单核苷酸多态性与冠心病之间的关联。
BMC Med Genet. 2008 Apr 2;9:23. doi: 10.1186/1471-2350-9-23.
2
The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.剪接变体LOXIN通过异源寡聚化抑制LOX-1受体功能。
J Mol Cell Cardiol. 2008 Mar;44(3):561-70. doi: 10.1016/j.yjmcc.2007.11.017. Epub 2007 Dec 7.
3
The G501C polymorphism of oxidized LDL receptor gene [OLR-1] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives.
E670G 多态性增加汉族人群冠心病的发病风险。
J Int Med Res. 2024 Oct;52(10):300060519892177. doi: 10.1177/0300060519892177. Epub 2019 Dec 16.
4
Lipoprotein receptor signalling in atherosclerosis.载脂蛋白受体信号通路与动脉粥样硬化
Cardiovasc Res. 2020 Jun 1;116(7):1254-1274. doi: 10.1093/cvr/cvz338.
5
Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery disease.股腘动脉疾病中OLR1和IL17A基因的上调及其与血糖和血脂水平的关联
Exp Ther Med. 2017 Mar;13(3):1160-1168. doi: 10.3892/etm.2017.4081. Epub 2017 Jan 24.
6
The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis.氧化型低密度脂蛋白受体1(OLR1)和前蛋白转化酶枯草溶菌素9(PCSK9)基因多态性对缺血性脑卒中的影响:一项Meta分析的证据
Sci Rep. 2015 Dec 15;5:18224. doi: 10.1038/srep18224.
7
Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.膜胆固醇调节内皮细胞中凝集素样氧化低密度脂蛋白受体1的脱落
PLoS One. 2015 Oct 23;10(10):e0141270. doi: 10.1371/journal.pone.0141270. eCollection 2015.
8
Scavenger receptor structure and function in health and disease.清道夫受体在健康与疾病中的结构和功能
Cells. 2015 May 22;4(2):178-201. doi: 10.3390/cells4020178.
9
Molecular mechanism of statin-mediated LOX-1 inhibition.他汀类药物介导的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抑制的分子机制。
Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.
10
Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia.凝集素样氧化型低密度脂蛋白-1 在子痫前期胎盘中血管功能障碍中的作用。
Biomed Res Int. 2014;2014:353616. doi: 10.1155/2014/353616. Epub 2014 Jul 6.
氧化型低密度脂蛋白受体基因[OLR-1]的G501C多态性与中国原发性高血压患者的易感性及血清C反应蛋白浓度相关。
Clin Chim Acta. 2008 Feb;388(1-2):200-3. doi: 10.1016/j.cca.2007.11.016. Epub 2007 Nov 29.
4
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.一项大规模重复研究中急性冠状动脉综合征报告的遗传风险因素未得到验证。
JAMA. 2007 Apr 11;297(14):1551-61. doi: 10.1001/jama.297.14.1551.
5
Dominant-negative lox-1 blocks homodimerization of wild-type lox-1-induced cell proliferation through extracellular signal regulated kinase 1/2 activation.显性负性lox-1通过细胞外信号调节激酶1/2激活来阻断野生型lox-1诱导的细胞增殖的同二聚化。
Hypertension. 2006 Aug;48(2):294-300. doi: 10.1161/01.HYP.0000229825.98545.5e. Epub 2006 Jul 3.
6
A death-promoting role for extracellular signal-regulated kinase.细胞外信号调节激酶的促死亡作用。
J Pharmacol Exp Ther. 2006 Dec;319(3):991-7. doi: 10.1124/jpet.106.107367. Epub 2006 Jun 26.
7
Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.动脉粥样硬化与凝集素样氧化型低密度脂蛋白清除受体
Trends Cardiovasc Med. 2006 Feb;16(2):60-4. doi: 10.1016/j.tcm.2005.12.001.
8
Low-density lipoprotein oxidized to various degrees activates ERK1/2 through Lox-1.
Atherosclerosis. 2006 Oct;188(2):245-50. doi: 10.1016/j.atherosclerosis.2005.10.046. Epub 2005 Dec 27.
9
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.凝集素样氧化型低密度脂蛋白受体-1(LOX-1):动脉粥样硬化及相关疾病发展中的关键因子。
Cardiovasc Res. 2006 Jan;69(1):36-45. doi: 10.1016/j.cardiores.2005.09.006. Epub 2005 Dec 1.
10
The Amber biomolecular simulation programs.琥珀生物分子模拟程序。
J Comput Chem. 2005 Dec;26(16):1668-88. doi: 10.1002/jcc.20290.